Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?

[cafead]

via

• Moderna and AstraZeneca reported positive results from a phase 2 study of AZD-8601.
• The mRNA heart failure drug appears to be promising.
• However, the clinical development of AZD-8601 will likely take a long time.

article source